Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2 for Patients With Stage IV Renal Cell Carcinoma
Phase of Trial: Phase II
Latest Information Update: 26 Sep 2012
At a glance
- Drugs B7-1-transduced tumour cell vaccine (Primary) ; Interleukin-2
- Indications Renal cancer
- Focus Therapeutic Use
- 04 Nov 2005 New trial record.